Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2025-12-02 00:00:00 ET · period of report 2025-12-01 · accession 0001628280-25-054856 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-02 | 2025-04-30 | BMRN | Hardy Alexander | CEO, Dir | A - Grant | $54.14 | +375 | 176.0K | +0.2% | +$20.3K | |
| 2025-12-02 | 2025-12-01 | BMRN | Hardy Alexander | CEO, Dir | F - Tax | $55.03 | -16.6K | 159.4K | -9% | -$911.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-30 | A | A | 375 | $54.14 | 175,958 | D | — | — | (F1) Represents the shares acquired by the reporting person on April 30, 2025, pursuant to the issuer's Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2025-12-01 | F | D | 16,570 | $55.03 | 159,388 | D | — | — |